ImpriMed, Inc.
AI-driven Personalized Medicine for Cancer Care
Biotechnology Research·0 Followers
Overview
ImpriMed, founded in 2017 in Silicon Valley, is a leading precision medicine startup revolutionizing cancer treatment with artificial intelligence. The company’s pioneering drug response prediction technology helps reduce costs, accelerate treatment, enhance efficacy, and improve the quality of life for patients. To date, the company’s technology has been deployed across more than 45 U.S. states, and 27,000+ canine and feline blood cancer tests have been performed as of 2026. ImpriMed is now poi...See more
Website
https://www.imprimedicine.com/Industry
Biotechnology Research
Company size
46 employees
Headquarters
Palo Alto, California
Founded
2017
Upgrade to view team
View current team members and their roles
Access founders information
Request warm introductions
Funding Rounds (1)
$10.0M • Funding Round
Announced on 9/21/2026
Open Positions(0)
No open jobs posted for this organization yet.
Company Updates
No updates available yet.